Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-16

Clinical Trial Update: Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis

View source ↗

Summary

A pharmacokinetic study evaluating infliximab and TNF concentrations in serum, stool, and colonic mucosa in patients with acute severe ulcerative colitis; the t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: Alimentiv Inc. | Conditions: Ulcerative Colitis | Status: ACTIVE_NOT_RECRUITING